InsidersTradesSigma
Follow the CalciMedica, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €19.6m. The latest transaction was reported on 29 June 2026 (Attribution). Among the most active insiders: Roberts Eric W. Every trade is accessible without an account.
96
Insider Decl.
n/a
Thresholds
€3m
77 ops.
Buy Volume
€3,105
9 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CalciMedica, Inc. Buy (bullish), based on 2 analysts. Average price target: US$10.50.
46Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 June 2026
Declarations96 total
1,182,621 sharesCommon StockSEC:0001189022-26-000002:0
248,972 sharesCommon StockSEC:0001267959-26-000003:0
Canonical exit: 23 Sept 2026 (T+90)
186,729 sharesCommon StockSEC:0001484729-26-000004:0
186,729 sharesCommon StockSEC:0001576244-26-000004:0
124,486 sharesCommon StockSEC:0001968793-26-000004:0
2,500 shares@ US$3.070.8% of flowCommon StockSEC:0001576244-25-000007:0
Canonical exit: 17 Dec 2025 (T+90)
3,400 shares@ US$2.67790.9% of flowCommon StockSEC:0001576244-25-000005:0
Canonical exit: 14 Dec 2025 (T+90)
5,000 shares@ US$3.121.6% of flowCommon StockSEC:0001576244-25-000003:0
Canonical exit: 11 Dec 2025 (T+90)
2,343 shares@ US$3.14880.8% of flowCommon StockSEC:0001415889-25-024256:0
Canonical exit: 8 Dec 2025 (T+90)
9,200 shares@ US$2.8632.9% of flowCommon StockSEC:0001415889-25-023364:0
Canonical exit: 26 Nov 2025 (T+90)
3,508 shares@ US$2.79281.1% of flowCommon StockSEC:0001415889-25-022850:0
Canonical exit: 19 Nov 2025 (T+90)
1,000 shares@ US$2.790.3% of flowCommon StockSEC:0001415889-25-022550:0
Canonical exit: 17 Nov 2025 (T+90)
9,563 shares@ US$2.819416.0% of flowCommon StockSEC:0001415889-25-022549:0
Canonical exit: 17 Nov 2025 (T+90)
5,076 shares@ US$2.89771.6% of flowCommon StockSEC:0001415889-25-022261:0
Canonical exit: 13 Nov 2025 (T+90)
1,584 shares@ US$2.5852.9% of flowCommon StockSEC:0001415889-25-022159:0
Canonical exit: 12 Nov 2025 (T+90)
1,000 shares@ US$3.6566.5% of flowCommon StockSEC:0001415889-25-020458:0
1,500 shares@ US$3.7750.6% of flowCommon StockSEC:0001415889-25-020164:0
Canonical exit: 20 Oct 2025 (T+90)
1,500 shares@ US$3.370.6% of flowCommon StockSEC:0001415889-25-020111:0
Canonical exit: 19 Oct 2025 (T+90)
1,000 shares@ US$3.400.6% of flowCommon StockSEC:0001415889-25-020052:0
Canonical exit: 19 Oct 2025 (T+90)
4,500 shares@ US$2.871.3% of flowCommon StockSEC:0001415889-25-019998:0
Canonical exit: 16 Oct 2025 (T+90)
2,000 shares@ US$2.880.7% of flowCommon StockSEC:0001415889-25-019997:0
Canonical exit: 16 Oct 2025 (T+90)
6,500 shares@ US$2.43231.8% of flowCommon StockSEC:0001415889-25-019822:0
Canonical exit: 12 Oct 2025 (T+90)
2,500 shares@ US$2.471.1% of flowCommon StockSEC:0001415889-25-019816:0
Canonical exit: 12 Oct 2025 (T+90)
5,000 shares@ US$1.60470.9% of flowCommon StockSEC:0001415889-25-019655:0
Canonical exit: 7 Oct 2025 (T+90)
1,000 shares@ US$1.85100.0% of flowCommon StockSEC:0001415889-25-019190:0
Canonical exit: 29 Sept 2025 (T+90)
25 of 96 declarations
Acerca de CalciMedica, Inc.
CalciMedica, Inc. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades relacionadas con la regulación del calcio. Cotiza en NASDAQ bajo el ticker XNAS.